GlassScriptPhysician profile
Sally A Shaver
NPI 1336533272
$3,018.96
in general payments reported to CMS, 2019-2025
16 companies · $1,109 in 2025
The $1,109 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $358 · 2022: $416 · 2023: $367 · 2024: $769 · 2025: $1,109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,748 · Education: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,748.42 |
| Education | $497.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $808.70 | 2021-2025 | Tremfya, Simponi, Simponi Aria |
| Novartis Pharmaceuticals Corporation | $554.19 | 2021-2025 | |
| Abbvie INC. | $549.15 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $326.94 | 2023-2025 | Ilumya |
| Regeneron Healthcare Solutions, INC. | $179.26 | 2021-2024 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $111.92 | 2024-2025 | Sotyktu |
| Lilly USA, LLC | $109.34 | 2022-2025 | Taltz, Ebglyss, Olumiant |
| Ucb, INC. | $80.72 | 2022-2024 | Bimzelx, Cimzia |
| Leo Pharma INC. | $70.23 | 2022-2024 | Adbry |
| Amgen INC. | $68.25 | 2024-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $56.00 | 2022-2025 | Nemluvio |
| Sanofi-Aventis U.S. LLC | $29.00 | 2021 | |
| Genzyme Corporation | $26.70 | 2025 | |
| Organon LLC | $16.71 | 2025 | |
| Incyte Corporation | $16.41 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $15.44 | 2024 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sally Shaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.